F-star Therapeutics Inc

NASDAQ:FSTX  
5.61
+0.16 (+2.94%)
Earnings Announcements

F-Star Therapeutics Reports Qtrly Loss Per Share Of $0.52

Published: 11/10/2021 13:27 GMT
F-star Therapeutics Inc (FSTX) - F-star Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update.
Qtrly Loss per Share of $0.52.
Q3 Earnings per Share View $-0.58 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $7.65 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.